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Detection of both isotypes of complement C4, C4A and C4B, in normal
human glomeruli. Monoclonal antibodies reactive against the comple-
ment C4A and C4B isotypic components were used in an immunoper-
oxidase technique for the histological study of normal human renal
tissue. Prominent staining with both antibodies was seen in the mesan-
gial areas of all normal kidney sections investigated. Occasional stain-
ing of arteriolar walls of the same tissues, however, was also observed.
Tn contrast, no mesangial staining was seen using monoclonal antibod-
ies reactive against other 'early' complement components, such as Clq
and C3. Specificity of the glomerular staining with the anti-C4 reagents
was demonstrated in two patients possessing only the C4A serum
component but lacking genetically the C4B locus products. As would be
predicted, glomerular staining with the anti-C4A reagent, but not
anti-C4B, was clearly demonstrable. It is concluded that both isotypes
of complement C4 are present in normal human glomeruli and thus
might be operative for normal mesangial function.
The HLA region is assumed to control immune responsive-
ness in man, and particular alleles of several HLA encoded
genes are useful markers of disease [1, 2]. Several studies have
already examined possible associations between HLA class I
and class II antigens and glomerulonephritis [31. In addition,
alleles of the HLA-linked complement genes (class III prod-
ucts), C4, C2 and factor B, are also used as genetic markers of
disease [4]. The fourth component of human complement, C4,
which is controlled by two highly polymorphic genes, C4A and
C4B [5, 6], has been particularly useful in this respect. It has
been shown recently that a rare variant of the C4B locus,
termed C4B2.9, is significant as an immunogenetic marker in
patients with glomerulonephritis [71. This disease association
with C4 raises the question, therefore, whether the genetically
determined, structural variants of C4 might be important in the
pathogenesis of diseases such as glomerulonephritis. Detection
of the early complement components Clq, C4 and C3, usually
by immunofluorescence, is interpreted as being due to deposi-
tion of immune complexes [8], either of preformed, circulating
immune complexes, or by in situ complex formation [91. Since
such staining is not observed in normal kidney, detection of
these complement components is usually indicative of glomer-
ulonephritis.
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In this study, we have used two monoclonal antibodies
reactive against C4 isotypic components (anti-C4A and anti-
C4B) in an immunoperoxidase staining technique on normal
human kidney, and demonstrate in the mesangium the presence
of the two isotypes, C4A and C4B, of complement C4.
Methods
Normal kidney tissue
Kidney tissue was obtained from ten patients undergoing
nephrectomy due to renal carcinoma. Macroscopically normal
tissue was kept in tissue culture medium, immediately
snap—frozen and stored at —80°C until preparation of cryostat
sections. Only histologically normal, tumor—free sections, as
judged by light microscopy, were used for immunoperoxidase
staining. In addition, percutaneous renal biopsies were obtained
from two patients with isolated proteinuria. One biopsy was
taken from a patient with acute pulmonary embolism immedi-
ately after non-successful resuscitation, One sample was ob-
tained at autopsy within eight hours postmortem from a patient
with myocardial infarction. All samples appeared normal on
microscopic examination and did not demonstrate immune
complex deposition.
Immunoperoxidase staining
Immunoperoxidase staining was performed with modifica-
tions as described in detail previously [10]. In brief, 5 sm
cryostat sections were used. The sections were fixed in acetone
for 10 minutes followed by a short wash in phosphate—buffered
saline (PBS) at pH 7.4. They were then incubated with the
appropriately diluted, primary monoclonal antibodies for 60
minutes. After incubation the sections were thoroughly washed
in PBS, and then reacted with peroxidase—conjugated rabbit
anti-mouse immunoglobulins (Dakopatts, Copenhagen, Den-
mark) for 60 minutes. After final washing in PBS, the sections
were stained with 3-amino-9-ethylcarbazole (Sigma Chemical
Corp., St. Louis, USA) and H202 (Merck, Darmstadt, W.
Germany) for 20 minutes in PBS, Counter—staining was done
with hemalaun, and the sections were mounted with
glycerine—gelatine (Merck) for microscopic evaluation.
When polyvalent antisera (two rabbit antisera, one goat
antiserum) were used as primary antibodies, the sections were
then reacted with peroxidase—conjugated swine anti-rabbit
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immunoglobulins (Dakopatts) and peroxidase—conjugated rab- Abit anti-goat (Sigma), respectively.
Monoclonal antibodies
Mouse monoclonal antibody (G2B12) reactive against C4B
locus products has been described and characterized in detail
elsewhere [11]. It reacts with a determinant on the a-chain of all
C4B variants.
Mouse monoclonal antibody (GIC4) against C4A locus prod-
ucts reacts with a common determinant on the a-chain of all
C4A variants.
Mouse monoclonal antibody against C4d is commercially
available (Cytotech, San Diego, USA).
Mouse monoclonal antibody against Clq has been character-
ized in detail elsewhere [12].
Monoclonal antibodies against various C3-epitopes have
been described elsewhere [131.
Monoclonal antibodies against human IgG and 1gM are
commercially available (Dianova GmbH, Hamburg, W. Ger-
many).
Polyvalent anti-C4 antisera
Polyvalent rabbit immunoglobulins anti-human C4 were pur-
chased from two commercial sources (Dakopatts and
Calbiochem—Behring Corp., La Jolla, California, USA). These
antisera were used in immunoperoxidase staining of tissue
sections, in immunoblotting of serum samples and in inhibition
studies.
Polyvalent goat—immunoglobulins anti-human C4 (Atlantic
antibodies, Scarborough, USA) were used in immunoper-
oxidase staining and in immunoblotting.
Inhibition of monoclonal antibody binding by polyvalent
antisera
Possible blocking of monoclonal antibody binding to the
a-chain of C4 by two polyvalent rabbit—anti-C4 antisera was
investigated. Kidney sections were incubated with polyvalent
anti-C4 immunoglobulins in various dilutions for 60 minutes
prior to immunoperoxidase staining with monoclonal anti-C4
antibodies. Monoclonal anti-C4 antibodies were also reacted
with kidney sections in the presence of excess polyvalent
rabbit—anti-C4 antibodies. Immunoperoxidase staining was per-
formed as described.
In addition, human C4 was immunoprecipitated from serum
with either polyvalent goat or rabbit anti-C4, subjected to
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and blotted onto nitrocellulose filters. The blots
were then incubated with excess polyvalent rabbit—anti-C4
prior to staining with monoclonal anti-C4 antibodies and
peroxidase—conjugated rabbit anti-mouse immunoglobulins
(Dakopatts).
Immunoblotting of C4 was performed as described [11]. C4
electrophoretic variants were determined in neuraminidase—
treated EDTA-plasma by immunofixation electrophoresis in
agarose gels [5].
Results
Two murine monoclonal anti-human C4 antibodies, one re-
active only with the C4A isotype (GIC4) and the other (G2B 12)
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Fig. 1. Reactivily of monoclonal anti-C4 antibodies determined by
SDS-PAGE analysis of immunoprecipitated C4 from individuals of
dfferent C4 phenotype followed by immunoblotting. The C4 pheno-
types of the samples are: track 1, C4A only (C4A3); 2, C4A + C4B
(C4A3, Bl); and 3: C4B only (C4B1). In A, the blot was developed with
anti-C4A (GIC4) with no staining in track 3 (that is, individual lacking
C4A). In B, the blot was developed with a polyclonal antiserum to C4
(goat) revealing staining of the three chains of C4 (a, /3 and y). In track
2, two molecular weight forms of the C4a-chain are apparent cone-
sponding to C4A-a (96.000 mol wt) and C4B-a (94.000 mol wt). In C, the
blot was developed with anti-C4B (G2B 12) with no staining in track 1
(that is, individual lacking C4B). Note that only the a-chain of C4 is
stained with the monoclonal reagents. Abbreviation HC is IgG heavy
chain.
reactive only with C4B, were used in an immunoperoxidase
technique for the histological study of normal renal tissue.
Reactivity of monoclonal anti-C4A and anti-C4B antibodies
The reactivity pattern of these monoclonal anti-C4 reagents is
shown in Figure 1. Here the reactivity of the monoclonal
anti-C4 reagents is compared to a polyclonal anti-C4 antiserum
(goat) using SDS-PAGE analysis of immunoprecipitated C4
from serum of individuals of different C4 phenotype, followed
by immunoblotting. It can be seen that in contrast to the
polyclonal reagent, both monoclonal antibodies were specific
for an epitope expressed on the C4-a chain, whereas the
polyclonal reagent was reactive with all three subunit chains (a,
/3, and y). Furthermore, the anti-C4A monoclonal antibody
(GIC4) was reactive only with the a-chain of C4A (96.000 mol
wt) and not C4B, whereas the anti-C4B reagent (G2B12) was
reactive only with the a-chain of C4B (94.000 mol wt) and not
C4A. The anti-C4A reagent was reactive with all C4A gene
products identified so far [14] and the anti-C4B reagent was
reactive with all well—defined C4B gene products [14].
Immunoperoxidase staining of kidney tissue
Figure 2 illustrates representative staining of tumor—free
kidney tissue from one nephrectomy out of ten. Similar results
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Fig. 2. Staining of normal human kidney with monoclonal antibodies against C4A and 4B complement components. A and B. Survey of renal
cortex with intensive staining of all glomeruli with the anti-C4A reagent (A) and the anti-C4B reagent (B) (x30). C and D. Higher magnification
(x210) of one glomerulus with staining of the mesangial area with anti-C4A (C) and with anti-C4B (D). Note also staining of artcriolar vessel wall.
were obtained with all other normal kidney specimens investi-
gated.
The staining pattern observed with the monoclonal antibody
against C4A was identical to that obtained with the antibody
against C4B, with intense staining in the mesangial areas of all
glomeruli. The staining appears to be cellular and was equally
distributed in the different mesangial regions. In addition, there
was staining of arteriolar vessel walls at the vascular pole of the
glomerulus, Occasionally, positive vascular extensions beyond
the glomerulus could be detected. It should also be noted that
interstitial arterioles showed distinct reactivity, although
weaker than that of the mesangial areas. Other vascular ele-
ments as well as constituents of the tubular system were,
however, consistently negative. Identical staining could be seen
in three experiments with the monoclonal anti-C4d antibody.
From these observations using the anti-C4 reagents, it was
important to determine if other 'early' complement compo-
nents, such as Clq and C3, could be similarly detected in
normal human kidney. Thus, a monoclonal antibody against
Clq and three against different C3 epitopes were also used in
the immunoperoxidase staining of normal kidney. None of
these antibodies showed any reactivity with normal kidney
sections. Two different polyvalent rabbit antisera and one goat
antiserum against C4 were similarly negative with normal
human kidney tissue. Neither reacted with monoclonal antibod-
ies against human IgG and 1gM with normal kidney (data not
shown).
To further examine the specificity of the tissue staining with
the monoclonal anti-C4A and anti-C4B antibodies, we investi-
gated cryostat sections obtained from kidney biopsies of two
patients. One patient, a 24-year—old woman, had the clinical
and laboratory findings of Systemic Lupus Erythematosus. The
other biopsy was taken from a 54-year—old man with
insulin—dependent diabetes mellitus and nephrotic syndrome;
histological examination showed diabetic glomeruloselerosis.
Complement C4 allotyping using immunofixation electrophore-
sis revealed that both patients possessed the C4A serum com-
ponent (C4A3) but lacked the C4B products in their serum. As
would be predicted on the basis of the C4 allotyping results, in
both patients only the anti-C4A antibody showed staining of the
inesangial area (Fig. 3A, SLE patient), whereas the anti-C4B
reagent was completely negative (Fig. 3B).
Inhibition of monoclonal antibody binding by polyvalent
antisera
In three experiments, polyvalent rabbit antisera failed to
block the binding of monoclonal anti-C4A and anti-C4B re-
agents, both in immunoperoxidase staining of kidney sections
and in immunoblotting of serum samples.
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Fig. 3. Biopsy specimen of a SLE-p atient possessing only the C4A serum component but lacking genetically the C4B locus products. Note staining
of mesangial area with antibody against C4A (A). Absence of staining with antibody against C4B (B) (x210).
Discussion
The main finding in this study is the demonstration of both
isotypes of complement C4, C4A and C4B, in normal human
glomeruli. This observation is further substantiated by positive
staining obtained with a monoclonal antibody reactive against
C4d. The notable absence of other 'early' complement compo-
nents, such as Clq and C3 as well as IgG and 1gM, suggests the
exclusive mesangial presence of C4, independent from immune
complex deposition.
The function of the glomerular mesangium seems to be
essential for homeostasis in renal physiology [15]. Mesangial
cells appear to be heterogeneous, and different functions are
displayed by these cellular subpopulations [16]. A considerable
portion of mesangial cells is believed to be of macro-
phage/monocyte lineage. Experimental data point to their im-
portant role in the removal or degradation of macromolecules
and immune complexes [17, 18]. It is uncertain, however,
whether the mechanisms of this clearance can be attributed
solely to phagocytosis by these cells, or whether other cellular
functions are involved. Membrane determinants such as Fe-
receptors [19] and receptors for C3b [20] have been observed in
human glomeruli and are thought to facilitate the uptake of
debris material. In addition, several 'immunological' cell sur-
face markers, including HLA class II antigens and Thy 1
antigen, have been identified on rat and human glomerular cells
117, 21, 221. Their biological role within the glomerulus, how-
ever, remains far from clear.
From the present study, the detection of HLA-class III
components, that is, the isotypes of complement C4 in normal
human glomeruli, raises questions regarding the origin and
function of C4 in the kidney. The staining pattern obtained with
our monoclonal antibodies indicates the expression and/or
production of C4A and C4B by mesangial cells. It is apparent
that not all mesangial cells express C4, since the staining is not
homogeneous throughout the mesangium. It remains to be
determined whether the cell population that expresses HLA-
class III antigens is identical with the population carrying
HLA-class II antigens.
The mesangial presence of C4 should be discussed in the
context of possible pathogenic mechanisms in autoimmune
diseases. Thus, mesangial cells may utilize the many biological
properties of complement C4, including its participation in
antigen processing and in the induction of a humoral immune
response [23]. Of particular importance would be its well
documented ability to bind to immune complexes [24] with
subsequent solubilization via activation of C3 [25]. It is cer-
tainly of interest that individuals with either a total or partial
deficiency of serum C4 are prone to the development of Lupus
Erythematosus [26, 27]. Further evidence for a direct role of C4
in disease pathogenesis has been suggested from the observa-
tion that drugs, such as hydralazine, that induce a lupus—like
syndrome, inhibit C4 in vitro [28]. Partial C4 deficiency has also
been reported in increased frequency in IgA nephropathy,
Henoch Schönlein Purpura and benign recurrent hematuria [29,
30].
Immunohistological staining of kidney biopsies from two
patients, one with SLE, the other with diabetic glomeruloscler-
osis, and both lacking the C4B serum component, demonstrated
the specificity of staining with the monoclonal anti-C4 reagents.
Glomerular staining was only seen using the anti-C4A anti-
body not, as would have been predicted, with the anti-C4B
reagent. Thus, it seems unlikely that there is some inadvertent
cross—reactivity of the antibodies with other mesangial matrix
components, such as fibronectin.
The assumption that the isotypes of complement C4 would be
expressed and function independently from each other is of
interest in terms of the reported difference in biological activity
between the two isotypes. It was recently shown that C4B is
about fourfold more active in immune hemolysis than C4A [31].
Similarly, the structural polymorphism of C4 might result in
functional heterogeneity. For example, the rare variant of C4,
C4B2.9, which is an immunogenetic marker in primary glomer-
ulonephritis [7], may be deleterious in terms of maintaining
regular mesangial function. The functional activity of the
C4B2.9 variant compared to other C4 variants should, there-
fore, be determined.
From these immunohistological studies it cannot be deter-
mined whether C4 is passively adsorbed on mesangial cells or
whether it is actively produced by these cells. To solve this
problem, studies on isolated or cultured mesangial cells are
required. Passive adhesion of C4 in the form of cytophilic
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immune complexes seems unlikely, however, since Clq and C3
were not detected in any of the tissue sections. Preliminary
results from patients with primary glomerulonephritis indicate
that the staining pattern of immune complexes is clearly dif-
ferent from that of normal kidney.
The staining of some arteriolar vessel walls with the mono-
clonal anti-C4 reagents also deserves further studies. Notewor-
thy is the close relationship of mesangia! cells and smooth
muscle cells in vessel walls which has recently been recognized
[32], Studies with fetal kidney cells are required to determine a
possible common origin of these cell types,
The reason why C4 was not demonstrable in normal kidney
using polyvalent antisera is not entirely clear. Since polyvalent
rabbit antisera failed to block monoclonal antibody binding in
immunoperoxidase staining and in immunoblotting, it is likely
that these reagents detect different or not accessible epitopes.
In conclusion, the studies indicate that C4 may be a normal
mesangial constituent of human kidney. The local presence and
putative function of both isotypes would provide a new clue to
our understanding of the direct involvement of immunogenetic
factors in the pathogenesis of renal autoimmune diseases.
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